Background and Purpose. Conventional electrical stimulation modalities are limited by their lack of opportunities for motor learning and, consequently, their impact on function. Other rehabilitative regimens necessitate affected hand and wrist movement for patients to be included, making them implausible for most patients. In light of these challenges, the current study examined the efficacy of a repetitive task-specific training (RTP) regimen using an electrical stimulation neuroprosthesis in stroke patients exhibiting no affected wrist or hand movement. Method. Eight chronic stroke patients (mean = 46.5 months) with moderately affected arm motor deficits participated in 30-minute therapy sessions occurring every weekday for 8 weeks. During the sessions, they wore the neuroprosthesis to enable performance of valued activities identified largely by the patients. To ensure transfer to their real-world environments, most sessions were home based, with the patients coming to the clinic for "tune-up" sessions (eg, adjusting the stimulation parameters, exercises, and/or fit of the device) twice every other week (a total of 8 clinical visits). Outcomes were evaluated using the Action Research Arm Test (ARAT) and the upper extremity section of the Fugl-Meyer Assessment (FM), the amount of use scale of the Motor Activity Log (MAL), and high-field functional magnetic resonance imaging (fMRI). Results. Before the intervention, patients exhibited stable motor deficits. After the intervention, they exhibited ARAT and FM score increases (+2.85 and +2.2, respectively). Postintervention fMRI revealed significant increases in cortical activation, possibly brought about by markedly increased affected arm use patterns on the MAL (+0.97). Conclusions. An affected arm RTP program incorporating NEURSTIM appears to increase affected arm use and elicit neural changes in more impaired patients. These factors may conspire to produce motor changes, although motor changes are smaller in this population than with less impaired patients. The program may act as a "bridge" to other promising regimens.
Introduction
Electrical stimulation (ESTIM), in which paretic muscles are made to contract in a cyclic pattern, is a common clinical rehabilitation technique for hemiparesis. The cyclic stimulation pattern is preset and causes muscle contractions in a single muscle group for a prespecified period of time. For the affected arm, ESTIM typically elicits simple contractions via surface electrodes, placed on the extensor carpi radialis longus, extensor carpi radialis brevis, extensor carpi ulnaris, extensor digitorum, and/or adductor pollicis. Spasticity decreases and range of motion increases have been observed after ESTIM use in patients exhibiting mild affected arm impairment. [1] [2] [3] Repetitive, task-specific practice (RTP) and motor learning appear necessary for neural and functional changes to occur. 4, 5 This finding may make conventional ESTIM suboptimal, as the muscle contractions during conventional ESTIM tend to be passively elicited (rather than the patient actively contracting the muscle), and participants do not necessarily engage in functional tasks or learn motor skills. 6 Recently, a fitted neuroprosthesis providing electrical stimulation (NEURSTIM) during RTP has been shown to reduce affected arm impairment and disability and convey functional changes. 7, 8 Existing, promising RTP regimens (eg, constraint-induced movement therapy) are most efficacious in patients initially exhibiting active movement in their affected wrist and fingers. However, 2 case studies 9,10 incorporating NEURSTIM report motor changes in patients exhibiting trace initial affected wrist and finger movement. These findings are of potential significance, as they suggest that a larger group of patients could benefit from RTP strategies.
In light of the above case study evidence and as a next step in this line of research, the current study examined the impact of an 8-week NEURSTIM protocol on affected arm use, functional limitation, and impairment. To begin to examine the mechanisms underlying NEURSTIM in this group of patients, we also administered high-field functional magnetic resonance imaging (fMRI) before and after intervention. We hypothesized that patients would exhibit increased affected arm use patterns, resulting in altered cortical organization patterns. These cortical changes were anticipated to produce decreased functional limitation and impairment levels.
Method Participants
Volunteers were recruited using advertisements placed in rehabilitative clinics in the midwestern United States. A research team member screened volunteers using the following inclusion criteria: (1) no active extension in the affected wrist or fingers, (2) stroke experienced >6 months prior to study enrollment, (3) a score ≥70 on the Modified Mini Mental State Examination (MMSE), 11 (4) age ≥ 18 ≤ 85, (5) only experienced 1 stroke, and (6) discharged from all physical rehabilitation. Patients also had to exhibit at least partial ability to move outside of synergies at the affected elbow, as indicated by Fugl-Meyer items IV and V (ie, movement mixing flexion and extension synergies; movements with little or no synergy dependence). Exclusion criteria were as follows: (1) participating in any experimental rehabilitation or drug studies; (2) pregnant; (3) uncontrolled seizure disorders; (4) excessive spasticity at the paretic elbow, wrist, or fingers, defined as a score of ≥3 on the Modified Ashworth Spasticity Scale (MAS) 12 ; (5) excessive pain in the paretic upper extremity, as measured by a score ≥4 on a 10-point visual analog scale; (6) mirror movements (ie, involuntary movements by the unaffected hand during attempts at unilateral movement by the affected hand); and (7) contraindication to fMRI procedure (eg, metal implants, claustrophobia, pacemaker).
Using these criteria, 12 patients were screened, and 4 were excluded because of excessive spasticity (n = 2) and movement in the affected wrist and/or fingers (n = 2). Eight patients were found eligible and agreed to participate (2 men; mean age = 57.6 ± 8.92 years, age range = 50-75 years; mean time since stroke onset = 46.5 months ± 30.1, range of onset = 8-104 months; 7 patients with right hemiparesis).
Apparatus
The Bioness H-200 is a microprocessor-based, Food and Drug Administration (FDA)-approved device. A forearm hand-molded orthosis contains an array of 5 surface electrodes ranging in size (2 × 2 to 6 × 4 cm), which are custom positioned for each patient over the extensor digitorum, extensor pollicis brevis, flexor digitorum superficialis, flexor pollicis longus, and thenar muscles. Electrodes, connected to a stimulator, delivered alternating current (AC) at a carrier frequency of 11 KHz, time modulated to bursts at 36 Hz. Particular muscle groups (eg, flexors, extensors) are stimulated either in isolation or sequentially depending on the particular program that is set up by the user and based on patient goals. The stimulator was set in an interrupted-pulse mode with contraction and relaxation intervals set at 7 seconds on and 6 seconds off. A 2-second ramp up and down was included in the 7-second time.
Assessments
The Motor Activity Log (MAL) is a semi-structured, valid, and reliable 13 interview measuring how much patients are using their affected arms for 30 activities of daily living (ADLs). Patients use a 6-point Amount of Use (AOU) scale to rate how much the they are using the more affected arm and a 6-point Quality of Movement (QOM) scale to rate how well they are using it. Patients' item responses are averaged to calculate a mean score that is indicative of their average AOU and QOM in the 30 ADLs. The sum of these scores is divided by the number of activities in which the participant regularly engages. Affected arm use is known to affect cortical reorganization and functional return, and quality of affected arm use was measured with the assessments described below. Thus, only the AOU scale was used in this study.
To measure affected arm limitation, we administered the Action Research Arm Test (ARAT) , 14 which is a 19-item test divided into 4 categories (grasp, grip, pinch, and gross movement), with 16 of the 19 ARAT items measuring distal regions of the arm (eg, pinching a ball bearing or marble between the thumb and each finger of the affected hand), with each item graded on a 4-point ordinal scale (0 = can perform no part of the test; 1 = performs test partially; 2 = completes test but takes abnormally long time or has great difficulty; 3 = performs test normally) for a total possible score of 57. For this test, patients were seated in a comfortable chair with a straight back, and the ARAT items that they had to grasp were placed on an adjustable table in front of them. Table  height was adjusted according to the needs of each patient. The ARAT has high intrarater (r = .99) and retest (r = .98) reliability and validity, 15, 16 all in stroke-induced hemiparesis.
Because perfect or near-perfect performance on the ARAT does not necessarily equate to absence of impairment, 17 the upper extremity section of the Fugl-Meyer (FM) scale 18 was used to assess upper extremity impairment. FM items are organized from having the patient attempt proximal movements (eg, shoulder abduction, internal rotation) to distal movements (eg, mass grasp, pincer grasp). Data arise from a 3-point ordinal scale (0 = cannot perform; 2 = can perform fully) applied to each item, and the items are summed to provide a maximum score of 66. The FM has been shown to have impressive test-retest reliability (total = .98-.99; subtests = .87-1.00), interrater reliability, and construct validity. 19, 20 
Study Design and Testing
A single-blinded pretest and posttest case series design was applied. This design was consistent with other case series examining neural mechanisms of particular stroke interventions 21, 22 and was believed to be appropriate at this stage in which we were attempting to more substantively determine NEURSTIM treatment effect. After screening and signing consent forms approved by the local institutional review board, the ARAT and FM were administered on 2 occasions 1 week apart (PRE-1, PRE-2), and the MAL was administered once. The Canadian Occupational Performance Measure (COPM) 23 was also administered at this time to identify occupational performance problems and to measure importance of tasks according to each patient. Patients identified the importance of the task to them, their perception of their performance with skills, and their satisfaction with their performance on a Likert scale from 0 to 10. Using these data, the therapist was able to pinpoint tasks that each participant wished to work on during therapy sessions and tailor a set of tasks for each patient to work on at home using the stimulator. The COPM is reported to be a valid, reliable, and responsive measure. 24, 25 One week after the second administrations of the FM and ARAT, each patient underwent fMRI. All patients were scanned using a 4.0 Tesla Varian Unity INOVA Whole Body MRI/MRS system (Varian, Palo Alto, California). This system is equipped for echoplanar imaging (EPI) to conduct fMRI research. Nonferromagnetic goggles were positioned to provide clear visualization of the stimuli and a radiofrequency (RF) coil was placed over the subject's head. Padding was inserted around the patient's head to minimize movement. Headphones were provided to block background noise and so that investigators could communicate with the patients during scan acquisition. A microphone in the scanner permitted verbal instructions for the fMRI task and allowed participants to communicate with the MRI technician in case of concern or discomfort. Following a 3-plane gradient echo scan for alignment and brain localization, a shim procedure was performed to generate a homogeneous magnetic field. To provide anatomical localization for activation maps, a high-resolution, T1-weighted, 3D brain scan was obtained using a modified driven equilibrium Fourier transform (MDEFT) sequence (T MD = 1.1 s, TR = 13 ms, TE = 6 ms, FOV = 25.6 × 19.2 × 19.2 cm, matrix 256 × 192 × 96 pixels, flip angle = 20 • ). 26 A midsagittal localizer scan was obtained to place 30 contiguous 5-mm axial slices that extended from the inferior cerebellum to encompass the entire brain. Patients then completed an fMRI session in which scans were acquired while performing the wrist flexion task that is described below. The fMRI data were acquired using a T2*-weighted gradient-echo EPI consisting of 30 contiguous 5-mm coronal slices to encompass the entire brain (TR/TE = 3000/25 ms, FOV = 25.6 × 25.6 cm, matrix 64 × 64 pixels, slice thickness = 5 mm, flip-angle array 75/180/180/90, NR = 96) using the blood oxygen leveldependent (BOLD) contrast mechanism. 27, 28 Each patient remained in the scanner for approximately 50 minutes.
fMRI Motor Task
Although the electrical stimulation intervention was targeted at deficient wrist extension/opening, using wrist extension as an fMRI motor task would have been too difficult for our patients. In our experience, making the fMRI task too difficult can cause patient fatigue and frustration at a minimum and, at worst, can cause movement of other body parts (eg, shoulder, elbow) to facilitate movement at the paretic joint. Thus, scans were acquired while patients performed 4 runs of an attempted wrist flexion task: 2 runs using the left wrist and 2 runs using the right wrist. The runs were identical for each hand. Patients were trained on the task prior to entering the fMRI scanner, and all were able to attempt the movement without excess body motion in other anatomical regions, including mirror movements on the unaffected side. During each scan, patients wore a brace restricting active wrist flexion to 10 • and disallowing other movements. During pretesting, this brace was not needed for affected wrist movement. However, we anticipated that some patients would exhibit new wrist flexion after intervention. Thus, to maintain consistency between arms (unaffected vs affected) and between tests (pre vs post), the brace was worn throughout testing. Directions were presented via goggles and via an auditory reminder prior to each movement or rest block. Directions read, "When you see 'move your left hand,' move your left hand down without moving your body. When the screen says 'stop moving,' remain still." During each run, patients received visual prompts every 30 seconds to either move their hand or to rest. Each run was 5 minutes long. Performance was visually monitored for adherence to the task while patients were in the scanner. All patients were encouraged to attempt moving at a consistent speed of 0.3 Hz.
Intervention
In a 1.5-hour session following the fMRI, the H-200 was fitted, and patients were educated on device use by a research team member. These individualized education sessions included proper donning/doffing, daily use of the device, written directions for proper device placement and use, and the COPM.
To ensure maximum opportunity for reintegration into patients' real-world environments, our regimen was purposefully home based in nature. Specifically, 1 week after their education sessions, patients participated in half-hour therapy sessions, requiring in-home practice of the activities that they had identified, while using the H-200. These sessions occurred every weekday over an 8-week period. Patients also came to the lab where education sessions occurred on 2 weekdays, every other week, (ie, first, third, fifth, and seventh weeks). The purpose of these sessions was to provide supervised half-hour training sessions to augment the "in-home" sessions, check home compliance, adjust device parameters, and make exercises more challenging, as needed. Thus, patients engaged in a total of 5 d/wk of half-hour practice over an 8-week period.
During "on" times of stimulation, the patient engaged in repeated practice of specific functional tasks identified using the COPM. Tasks included grasping and releasing a favorite cup during "on periods" of flexor/extensor stimulation and pinching small objects (eg, a key) between the thumb and lateral side of the index finger during "on" times of stimulation.
Posttesting
One week after the final therapy session, each patient returned to the laboratory where pretesting occurred, and the MAL, FM, and ARAT were again administered by the same examiner who administered pretests. The examiner was blinded in that he was unaware of the intervention in which patients had participated. fMRI was also readministered at this time and at the same location as preintervention scanning.
fMRI Data Processing and Analysis
Images were processed, analyzed, and visualized with AFNI (Analysis of Functional NeuroImages). 29, 30 Following acquisition, images were reconstructed using in-house software developed in IDL (Interactive Data Language), which converts raw data into AFNI format. In AFNI, MDEFT (structural) and EPI (functional) images were coregistered using scanner coordinates. Functional images were corrected for motion to the third volume of the first run using a 6-parameter rigid body transformation with Fourier interpolation. 31 After realignment, each volume was inspected for residual signal artifact using a semi-automated algorithm in AFNI to identify questionable volumes. These volumes were removed from further analysis if visual inspection indicated uncorrectable head movement (ie, within-TR head motion or scanner signal artifact affecting approximately 30% or more of voxels within the image). One patient was removed from further analysis at this step because of excess uncorrectable movement. Using an automated affine registration tool in AFNI (@auto_tlrc script), the MDEFT image set was normalized to Talairach space 32 by matching to the ICBM452 template. 33 The EPI data sets were normalized to Talairach space by adopting the MDEFT transformation, spatially smoothed with a 6-mm full-width, half-maximum Gaussian filter. The EPI data were then transformed to Talairach space using automated affine registration tools in afni (@auto_tlrc) and resampled to 3 × 3 × 3 mm. For the participant with an affected left hand, all brain images were right-left reversed to allow for group analysis of the interventional related changes. All changes are described in terms of the right or left hemisphere, which corresponds to the unaffected and affected hand, respectively. The 2 runs for the affected hand were concatenated and analyzed as a block design using a deconvolution algorithm that fits a box-car reference function to the EPI time series to assess the average magnitude of the fMRI response to the flex/extend condition for the duration of the block. Head movement estimates derived from the motion correction step were included as regressors of no interest in the deconvolution analyses to help reduce the impact of any head movement-related signal intensity changes. In addition, low-frequency components of the signal, including linear, quadratic, and cubic drift, were removed. After deconvolution, the activation magnitude estimates were entered as dependent measures in t tests to identify brain activation effects of interest across the group of 8 patients. The activation maps generated by 1-sample t tests were thresholded at a voxel level of P ≤ .025 and a cluster threshold of 10 voxels or more for each visit. We acknowledge that an individual voxel threshold of P < .025 with a cluster size of 10 voxels or more is a liberal threshold; however, because of the expected variability in brain activation profiles across stroke patients and the small number of participants, we used this lenient threshold to balance between Type I and Type II errors.
The Talairach daemon 34 was used to identify the locations of clusters exceeding these thresholds.
Results

Behavioral Outcomes
During the pretesting phase, all patients exhibited stable motor deficits. This was evidenced by FM scores that did not differ from each other between pretesting interventions (PRE-1 = 23.0 ± 6.2, PRE-2 = 23.3 ± 6.5) and by ARAT scores that did not differ from each other between pretesting interventions (PRE-1 = 9.4 ± 12.0, PRE-2 = 9.0 ± 12.0). Comparison of each patient's motor deficits at pretesting with those reported at therapy discharge in medical records further confirmed motor deficit stability.
After intervention, the mean FM score increased to 26.0 (mean change = +2.85). Likewise, the mean ARAT score increased to 11.4 (mean change = +2.2), with most changes occurring on the ARAT grasp scale. Functionally, patients reported new ability to grasp and hold large objects (eg, a coffee mug; a soda can).
After intervention, patients reported increases on the MAL AOU scale (1.46-2.43; mean change = +0.97). They also completed an average of 5.2 more MAL items after intervention. All of these scores are depicted in Table 1 .
Neuroimaging Outcomes
No significant changes were identified between preintervention and postintervention activation for the wrist flexion task using the unaffected hand at our a priori statistical threshold (P ≤ .025). Figure 1 shows activation patterns that remain when preintervention activation is subtracted from postintervention activation while performing the affected wrist flexion task. For the affected hand, significant increases in BOLD signal volume at P ≤ .025 were present after intervention in the right precentral and postcentral gyri (22, -18, 48) (47, -29, 43), right inferior parietal lobule (47, -29, 43), right middle frontal gyrus (33, 13, 38) , and right precuneus (13, -75, 38) . Additional increases in activation were present in the basal ganglia and thalamus, bilaterally. Specifically, changes were noted in the left and right caudate (-35, -27, -5) (21, -33, 15), left and right lentiform nuclei (-17, -0, 5) (27, -0, 0), and the left and right thalamus (-12, -19, -15) (18, -23, 5). Temporal lobe structures that showed BOLD signal increases included the right parahippocampal gyrus (27, -51, 5) and the right superior temporal gyrus (44, -22, 5) . Occipital lobe increases in activation were seen at the right middle occipital gyrus (34, -63, 5), right lingual gyrus (20, -54, 5), and right cuneus (9, -72, 33). The above-described changes are detailed in Table 2 .
Discussion
Therapies incorporating RTP appear to increase affected arm use and function in patients exhibiting minimal arm impairment. However, a paucity of existing treatments increases affected arm use and movement in patients with moderate impairment. Building on 2 promising case studies, this case series examined the impact of NEURSTIM Participant  MAL PRE  MAL POST  FM PRE-1  FM PRE-2  FM POST  ARAT PRE-1  ARAT PRE-2  ARAT POST   1  1.7  2.5  22  23  29  4  4  10  2  0  0  16  17  17  0  1  0  3  2.15  2.8  27  27  27  16  16  22  4  2  2.8  24  25  28  3  2  8  5  2.9  3.3  35  36  38  39  38  40  6  0  2  16  15  19  2  1  0  7  0  3.6  17  17  19  2  1  0  8 2.9 2.4 27 27 31 9 9 DNC "DNC" denotes that the patient did not complete the test as she had to leave the testing session prematurely. ARAT, Action Research Arm Test; FM, Fugl-Meyer assessment; MAL, Motor Activity Log. Figure 1 . The difference in brain activation for affected wrist flexion/extension between postintervention and preintervention functional magnetic resonance imaging (fMRI) sessions. Regions in orange and yellow demonstrated increases in brain activation postintervention (P ≤ .025, thresholded at N > 10 voxels, in raw MR units). The underlay is the AFNI template brain image (ICBM-452). The overlay is t test results obtained by combining data for all the patients. Brain images in the top row span -5 to +15 mm relative to the AC-PC. The bottom row of images spans +31 to +51 mm relative to the AC-PC. Slice thickness is 5 mm. Maps are displayed according to neurological convention combined with RTP on affected arm use, functional limitation, impairment, and cortical organization in stroke patients with moderate affected arm impairment. As hypothesized, patients exhibited marked affected arm use changes, as measured by the MAL AOU scale. The magnitude of the amount of use changes was not only of functional significance; it was comparable to that reported with other upper extremity interventions. 35, 36 MAL AOU data were also corroborated by the fact that patients reported attempting more ADLs on the MAL after intervention (a mean of 5.38 items before intervention vs 10.5 items after intervention). Qualitatively, patients also reported using the affected arm for ADLs after intervention, such as grabbing a soda can (ie, new finger flexion) and bringing it to their mouth (ie, elbow flexion) and personal grooming (eg, grasping and using a comb). This finding corroborated MAL data suggesting increased affected arm use for ADLs.
An additional hypothesized finding was increases in fMRI BOLD signal after intervention. Specifically, increases in right precentral and postcentral gyri were observed during the wrist flexion task, in addition to other structures contralateral to the lesion. In healthy individuals, one would expect to see left primary motor (dorsal precentral gyrus) activation associated with right wrist movement. Some data suggest that, after stroke, the hemisphere contralateral to the lesion may assist with taking over motor function for the ipsilateral hand. 37, 38 Our data supported this hypothesis, as increases in activation were seen in the right primary motor areas (precentral gyrus) after therapy.
Our fMRI results are consistent with research that suggests that the contralesional sensorimotor cortex is an available mechanism for compensating for stroke-induced motor impairments. 35, 39 In addition, our results demonstrated ipsilesional increases in activation in the thalamus and basal ganglia following therapy. These structures share both inhibitory and excitatory connections with the motor cortex and may contribute to either increased inhibition of dysfunctional ipsilesional motor cortex or excitation of functional ipsilesional regions. Increased activation in these regions after therapy may have important implications about their importance for functional recovery of upper limb motor movement.
As stated earlier, increased affected arm use via RTP is believed to elicit neural changes that, in turn, convey motor changes. Consistently, above-described affected arm use and neural changes coincided with small decreases in affected arm limitation and impairment. Although relatively meager in magnitude, patients exhibited increased ability to flex their wrists and move some digits, which conveyed new ability to grasp large objects. Some patients also exhibited some new extension at the elbow and wrist, which also facilitated some ADLs. Importantly, patients did not exhibit the magnitude of functional changes reported in previous NEURSTIM cases with patients with no initial affected wrist or finger movement. 9,10 However, patients in those studies appear to have initially exhibited more movement than in the current study, as evidenced by ARAT and FM score comparisons. In all, these findings were relatively consistent with the magnitude of findings reported by other researchers using NEURSTIM and similar measures. For instance, Alon and colleagues 7 showed comparable benefit on the Fugl-Meyer among more acute stroke patients. The above finding of less profound motor changes appears consistent with data suggesting that the efficacy of RTP regimens may diminish in more impaired patients. 40, 41 For example, a recent review indicates that patients showing some initial movement in the affected wrists and fingers exhibit the largest motor increases in stroke clinical trials. 42 Nonetheless, we believe that regimens such as the one herein described have a place in the therapy milieu because (1) the opportunity to induce patients to reintegrate the affected arm in meaningful ADLs and (2) postintervention patterns of wrist flexion, as well as the ability to perform some new ADLs, will make patients eligible for other efficacious modalities. 43 Restated, NEURSTIM may act as a "bridge" to participation in other promising therapy regimens.
Several studies suggest that more normalized (ipsilesional) activation patterns in individuals after the stroke correlate with better upper limb recovery. 44, 45 This hypothesis appears to relate to our findings, as our patients did not show optimal recovery patterns, and activation was largely increased in the contralateral hemisphere.
Although findings were positive, some study limitations should be noted: (1) a case series design was used, without a control group, so it is not fully possible to conclude that changes were attributable to the intervention. However, we would also note that patients were stable and not receiving any other interventions at the time of this study. It thus seems highly likely that changes were attributable to the intervention provided. (2) There was no follow-up period, so duration of effects herein observed remain unknown. Now that a treatment effect is known, future studies should examine NEURSTIM long-term effects. (3) It is unknown if the fMRI changes are larger than day-to-day variation. As a solution, future work should administer fMRI longitudinally (as opposed to cross-sectionally, as has been done in this and other fMRI studies). This design will allow researchers to discern normal change versus change observed from interventions such as NEURSTIM. (4) Although NEURSTIM was provided in synchrony with performance of ADLs, it was still passive. We speculate that stimulation in which patients better control the stimulation could possibly enhance the outcomes, even in this more impaired population. (5) Last, although it has been used in numerous previous studies, the MAL has some inherent weaknesses associated with recall bias and subjectivity, given that it is a qualitative measure. Future researchers may wish to complement MAL use with a more objective measure of affected arm use, such as activity monitors.
Conclusion
An affected arm RTP program incorporating NEURSTIM appears to increase affected arm use and elicit neural changes. These factors are believed to conspire to produce motor changes, as reported herein. The program may act as a "bridge" to other promising therapy regimens.
